Horizon Pharma Plc (HZNP) Should Benefit From M&A - Mizuho

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Horizon Pharma Plc (HZNP) Should Benefit From M&A - Mizuho

Horizon Pharma (HZNP) Primary Care Sustainable, Rare Disease Solid - PiperJaffray

May 9, 2016 1:02 PM EDT

Piper Jaffray analyst, David Amsellem, cut his PT on Horizon Pharma (NASDAQ: HZNP) to $34 from $44 on a lower PE, 13x down from 17x. The lower PE incorporates the greater discount placed on specialty pharma companies of late. The firm maintained its Overweight... More

Horizon Pharma (HZNP) Tops Q1 EPS by 4c

May 9, 2016 7:10 AM EDT

Horizon Pharma (NASDAQ: HZNP) reported Q1 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the quarter came in at $204.7 million versus the consensus estimate of $197.73 million.

The Company confirms its full-year and second-quarter net sales and adjusted EBITDA... More